title: Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.
abstract: In order to investigate the role of sucralfate in active ulcerative colitis, 60 patients were randomized to receive either sucralfate enemas (20 g/100 ml) or methylprednisolone enemas (20 mg/100 ml). The enemas were administered twice daily for one week, and then once daily for three weeks. Clinical evaluation was documented at entry and at two weeks and four weeks. The sigmoidoscopic appearance of the rectal mucosa was scored, and rectal biopsies taken at entry and at four weeks. Results indicated similar reduction in diarrhea and rectal bleeding at two weeks and at four weeks. Sigmoidoscopy demonstrated similar significant improvement in the macroscopic appearance of the rectal mucosa in both groups (8.28 to 6.20 in sucralfate group, P < 0.02; and 8.72 to 6.36 in the methylprednisolone treated group, P < 0.04). Histologic assessment, likewise, showed similar improvements in the two groups. This study indicates that sucralfate enemas may be useful in the treatment of ulcerative proctosigmoiditis.
authors.affiliation: Gastrointestinal Clinic, University of Cape Town, South Africa.
authors.forename: J P
authors.initials: JP
authors.lastname: Wright
authors.forename: T A
authors.initials: TA
authors.lastname: Winter
authors.forename: S
authors.initials: S
authors.lastname: Candy
authors.forename: I S
authors.initials: IS
authors.lastname: Marks
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000473:pathology; D004733:Enema; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D012007:Rectum / Q000187:drug effects / Q000473:pathology; D016037:Single-Blind Method; D013392:Sucralfate / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D005938:Glucocorticoids; D013392:Sucralfate; D008775:Methylprednisolone